HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predictors for postoperative liver metastasis in patients with resectable pancreatic cancer.

Abstract
Although postoperative liver metastasis for pancreatic adenocarcinoma is a major problem that directly influences patient outcome, there is no useful predictor reported to date. We reviewed 174 surgically resected pancreatic tubular adenocarcinomas for their clinicopathological data and time for the appearance of postoperative liver metastasis to occur, using the Cox proportional hazards model. Multivariate analysis revealed three independent risk factors for postoperative liver metastasis: G3 histological grading, venous system invasion, and increased preoperative carbohydrate antigen 19-9. Furthermore, the additive effect of these three variables for predicting postoperative liver metastasis was evaluated. Two-year disease-free survival rate for the liver in patients without any factor was 82%, which was significantly higher than that of those with one, two, or three factors (35%, 33%, or 0%, respectively). Our data suggest that these three conventional clinicopathological variables are useful to predict postoperative liver metastasis in patients with pancreatic cancer.
AuthorsShuichi Fujioka, Takeyuki Misawa, Tomoyoshi Okamoto, Takeshi Gocho, Yasuro Futagawa, Katsuhiko Yanaga
JournalInternational surgery (Int Surg) 2008 Nov-Dec Vol. 93 Issue 6 Pg. 324-30 ISSN: 0020-8868 [Print] Italy
PMID20085041 (Publication Type: Journal Article)
Chemical References
  • CA-19-9 Antigen
Topics
  • Adenocarcinoma (secondary, surgery)
  • Adult
  • Aged
  • Aged, 80 and over
  • CA-19-9 Antigen (blood)
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Liver Neoplasms (secondary)
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Invasiveness
  • Pancreatic Neoplasms (pathology, surgery)
  • Postoperative Period

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: